Water metabolism plays an essential role in the gical states such as dehydration, syndrome of inappropriate secretion of antidiuretic hormone (SIADH ), homeostasis of body fluids in animals and humans. It is regulated by arginine vasopressin (AVP), renal func-liver cirrhosis with ascites and congestive heart failure [3, 8, 9]. The 5∞ flanking region of the AQP-2 gene tion and water drinking. The disorders of water metabolism result in an increase or decrease in body water contains an adenosine 3∞,5∞-cyclic monophosphate (cAMP)-responsive element and stimulation of gene and/or fluid, which manifest as hyponatraemia, hypernatraemia, polyuria, dehydration or oedema. In the transcription of AQP-2 by cAMP is observed in experimental promoter assay [10] . All these data indicate pathogenesis of such pathological conditions AVP is involved either directly or indirectly. One is often faced that AQP-2 is the AVP-regulated water channel in renal collecting duct cells. with the dilemma to elucidate the exact mechanism of action. A radioimmunoassay for AVP has been established for reliable measurements of plasma AVP levels, but even under pathophysiological conditions plasma AVP does not vary widely. Furthermore, physiological stimulants of plasma osmolality (Posm) and circulatory blood volume are tightly interrelated with one another. AQP-2 is excreted in the urine Therefore AVP release from the posterior pituitary is unexpectedly complicated in pathological states of AQP-2 is, in part, excreted into the urine, which water metabolism [1,2]. Accordingly, in the analysis accounts for approximately 3% of AQP-2 of renal of disorders of water metabolism one has to resort to collecting ducts in the rats [11,12]. Urinary AQP-2 analysis of tolerance tests monitoring urine volume was detectable in both soluble and membrane-bound and urinary osmolality ( Uosm) e.g. during water forms by Western blot. Immunoelectron microscopy deprivation, hypertonic saline infusion, oral water load showed that AQP-2 was present in membrane and so on.
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structures probably derived from membrane vesicles. Urinary AQP-2 was quantitatively determined by radioimmunoassay, using the antibody against the C-terminal of AQP-2. Exogenous administration of AVP elicited a prompt increase in urinary excretion of AQP-2 in normal subjects and patients with central diabetes insipidus, but not in patients with nephrogenic NaCl )-infusion test was performed after drinking References 20 ml/kg water [13] . After the infusion of 5% NaCl, Further study will be necessary to evaluate its role in 11 
Introduction
are still lacking [5] . The cotransporter consists of 12 transmembrane domains and an intracellular aminoGitelman syndrome is an autosomal recessive inherited and carboxyterminal region ( Figure 1 ). Most of the disorder first described by Gitelman et al. in 1966 [1] .
mutations observed in the European consortium are They characterized this syndrome by hypomagnesaelocalized in the carboxyterminal region. In rat and mia, hypokalaemia, and impaired renal conservation human the NaCl cotransporter was localized using the of potassium and magnesium. The clinical symptoms in situ hybridization technique. In the human as well consisted of transient episodes of muscle weakness and as in the rat the cotransporter was present in the distal chronic non-specific dermatitis in two of the three nephron beginning in the initial distal convoluted patients. Treatment by aldactone or triamterene tubule. In humans, in contrast to the rat, expression decreased the urinary potassium loss but did not extended into the connecting tubule [6 ] . influence the magnesium excretion. Further clinical
In addition Barry et al. [7] showed that the thiazidestudies allowed a better definition of Gitelman sensitive NaCl cotransporter was expressed in osteosyndrome, separating the syndrome from Bartter blast-like cells, suggesting a direct effect of thiazide on syndrome [2, 3] . The distinction between the bone-synthesizing cells. two syndromes is still not perfect ( Table 1) . Genotype-phenotype studies will ultimately indicate the borders between the syndromes [4] .
Pathophysiology

Molecular basis of Gitelman syndrome
The distal tubule consists of several nephron segments. The first segment is the distal convoluted tubule starting at the macula densa and ending with the connecting The demonstration of linkage of Gitelman syndrome to the locus encoding the renal thiazide-sensitive NaCl tubule. The latter segment connects the distal convoluted tubule to the collecting duct. Both segments cotransporter ( TSC ) and the identification of mutations, provided the molecular basis of Gitelman syn-contain the NaCl cotransporter in humans. A schematic view of the NaCl and Ca transport in the distal Clinical symptoms convoluted tubule is given in Figure 2 [8] . Na/K ATPase situated at the basolateral membrane is Often the syndrome is first discovered in adults during responsible for the low sodium and high potassium routine investigation. Most of the patients report recurconcentration in the cell. An apical NaCl cotransporter rent periods of carpopedal spasms when the intestinal is present which is inhibited by thiazide diuretics and absorption of magnesium is decreased (vomiting, diawhich is defective in Gitelman syndrome. rrhoea) or during fever. Two other modes of apical entry of sodium have Fatigue, hardly noted by some patients, can be so been described in this segment. The first is an apical severe that daily activities cannot be performed. The Na+ conductance, which is sensitive to amiloride. The severity of these symptoms is only to a certain degree second mode consists of parallel Na/H antiport and reflected by the lowering of the serum potassium Cl/base exchange. The inhibition of NaCl absorption concentration. The patients are growing normally and in the distal tubule has consequences for the calcium are not complaining of polyuria or polydipsia. and magnesium reabsorption. Inhibition of the NaCl
In some families chondrocalcinosis is reported, causabsorption results in enhanced calcium reabsorption. ing swelling, local heat, and tenderness over the affected Two explanations are offered. By inhibition of the joints. In experimental studies similar lesions are sodium entrance into the cell, voltage-gated Ca2+ induced by magnesium deficiency [13] . It is not clear channels are activated by membrane hyperpolarization. why not more patients are affected by chondrocalAnother possibility is that the decrease in intracellular cinosis. Chondrocalcinosis may occur in patients with Na+ augments the calcium efflux through the basolat-isolated magnesium loss. eral Na+/Ca2+ exchanger. Although chronic thiazide treatment may lower the serum magnesium concentration it is rarely as low as in Gitelman syndrome [9] .
Treatment
The magnesium loss observed in Gitelman syndrome is still unexplained. Inhibition of Na+ transport in the distal tubule will result in a stimulation of Mg2+ Many patients with Gitelman syndrome remain untreated. When we accept that chondrocalcinosis is uptake as shown also for calcium [10, 11] . In a recent review Quamme [12] suggests that the increased mag-due to magnesium deficiency, it is an argument for supplementation of magnesium. Normalization of nesium excretion may be due to associated hypokalaemia. Most of the patients with Bartter syndrome, serum magnesium is, however, difficult to obtain, as high doses of magnesium cause diarrhoea. however, with a similar degree of hypokalaemia have a normal serum magnesium. The increased renal potasHypokalaemia can be treated by drugs that antagonize the activity of aldosterone or block the sodium sium excretion is due to the increased distal delivery of Na+ and water to the cortical collecting duct. channel in the distal nephron. (ii) Na+/H+ and Cl− base antiporters working in parallel with the protonated base (HB) being recycled across the apical membrane; (iii) amiloride-sensitive sodium channel. Sodium entering the cell across the apical membrane will be extruded by a basolateral Na+−K+−ATPase, while K+ and Cl− can exit via basolateral potassium and chloride channels respectively. Calcium enters the cell via an apical calcium channel and is extruded at the opposing basolateral membrane by Ca2+−ATPase and Na+/Ca2+ exchangers. The molecular mechanism of magnesium reabsorption remains to be established. Across the epithelium a lumen-negative potential difference exists which drives the paracellular movement of chloride.
by mutations in the thiazide-sensitive NaCl cotransporter. Nat
We prefer the treatment by amiloride, if necessary lent flow condition and a long vessel distance within Other methods for the diagnosis of RAS are susceptible the excited volume decrease signal intensity. Hence, to a variety of problems such as operator skill, contrast the TOF technique rarely images more than the proxmaterial nephrotoxicity, poor reproducibility between imal 2-3 cm of the renal arteries. institutions and low values of sensitivity and specificity.
Phase-contrast MRA provides an image of vessels Hence, there is still a need for a non-invasive, accurate, by a different technique. As moving spins (e.g. flowing reliable and acceptable test for the screening and blood ) pass through the imaging volume, they are diagnosis of patients with suspected RAS, to reduce bombarded by radiofrequency pulses within the magthe number of negative angiograms that are performed.
netic field. This results in the spins undergoing a change Due to its very rapid evolution during recent years, in phase relative to stationary tissues, which undergo the diagnostic accuracy of magnetic resonance angiogno phase alteration. Also, the phase shift is broadly raphy (MRA) has improved substantially and it is a proportional to the velocity of the moving spins. This candidate to achieve this diagnostic goal.
phase difference is used to image moving blood.
Technique of magnetic resonance angiography Diagnosis of renal artery stenosis by MRA
The physics of MRA are complex, and a comprehensive grasp of their fundamentals is not really necessary Studies applying TOF-MRA showed a comparatively for clinical practice. However, the user should under-low diagnostic accuracy with reliable visualization of stand the concepts in order to facilitate diagnostic only the first 3 cm of the renal arteries. The sensitivity interpretation. Conceptually, MRA is based on the and the specificity for the detection of RAS had a wide phenomenon that nuclei of certain atoms including scatter [1] [2] [3] [4] [5] [6] [7] . Studies using phase-contrast MRA conhydrogen-1 have a magnetic moment and that they sistently showed a better overall diagnostic accuracy. interact with magnetic fields. A strong electromagnetic The sensitivity for RAS >50% was between 80 and pulse destabilizes the protons, and their return to stable 100%, and the specificity ranged from 93 to 99% baseline (relaxation) emits energy (magnetic resonance) [2, [6] [7] [8] [9] [10] [11] [12] [13] . MRA reliably visualized all main renal arterthat can be measured. MR imaging gives resonance ies, but there was a strong tendency to overlook small signals limited to body water and some lipids. The accessory renal arteries. Further drawbacks were the distribution and intensities of the magnetic resonance inability to visualize intrarenal arteries, to depict are converted to grey-scale values. Time-of-flight fibromuscular dysplasias reliably and to graduate the ( TOF ) and phase-contrast sequences are the two main stenosis correctly. techniques for imaging flowing blood in vessels by A major diagnostic improvement was achieved by MRA, and they rely on magnetic resonance of the application of paramagnetic 'contrast-material' (i.e. hydrogen of water. Each of these sequences may be gadopentate dimeglumine), that can shorten the relaxaacquired as either two-dimensional (exciting sequen-tion time of blood. The consequence is a high intravastially one slice at a time) or as a three-dimensional cular signal and an ultrashort breath-hold acquisition (when a whole volume is excited at the same time) of magnetic resonance data within 30 s, avoiding formulation. TOF techniques are based on the signal motion artefacts and improving image quality significantly. Studies utilizing the breath-hold gadopentate dimeglumine-enhanced technique gave values of sen- be the diagnostic procedure of choice in these patients. 9 . Silverman JM, Friedman ML, VanAllan RJ. Detection of main renal artery stenosis using phase-contrast cine MR angiography.
The current published results support the view that a 
Introduction
of an immunological response, may mediate the cellto-cell interaction and modulate the cellular level of Bioincompatibility, as it relates to haemodialysis, is a activation. Moreover, each cytokine can modulate the concept based on both scientific and marketing considsynthesis or the actions of the others in a complex erations. It can be partly defined, as reported by the network of interactions. They are active at picomolar 1st Consensus Conference on biocompatibility, held in and femtomolar concentrations and may affect cellular Koenigswinter on March 1993, as 'different reactions responses both proximal and distal to the site of induced by different materials, procedures, and devices secretion [3] . that have not all as yet been fully investigated' [1] . In It has been clearly shown that the contact of the the last two decades, there has been growing knowledge bloodstream with extracorporeal circulation devices on cellular and humoral immunological events occurcan unbalance several homeostasis systems, including ring during haemodialysis procedures. Such increased the cytokine network [4] . Each of these systems is understanding of the immune mechanisms underlying under a tight feedback control with several checkthe bioincompatibility phenomena has been obtained points and balances whose main goal is to maintain by the application of several sophisticated immunolothe organism functions in a 'normal state'. gical procedures and, more recently, of molecular Haemodialysis, therefore, modify this 'normal state' biological techniques [2] . Thus, while in the early days inducing a state of 'bioincompatibility'. of haemodialysis major emphasis has been given to
The monocyte seems to play a key role in the thrombogenicity and toxicity of the materials used, bioincompatibility reactions as one of the main sources today it is appreciated that such material may influence of cytokine secretion [5] . Indeed, upon contact between several homeostasic systems including the cytokine blood and the extracorporeal system, monocytes are network.
activated directly or indirectly, with the subsequent This editorial comment aims, necessarily in an release of several proinflammatory cytokines, such as incomplete fashion, to summarize some of the most interleukin (IL)-1, IL-6, IL-8, tumour necrosis factor important studies on cytokines and biocompatibility.
( TNF )-a, and monocyte chemotactic factor (MCP)-1. Three structurally related polypeptides belong to the Cytokines involved in 'bioincompatibility' reactions IL-1 family: IL-1a, IL-1b and IL-1 receptor antagonist (RA) [6, 7] . The first two polypeptides, binding specific Cytokines are a family of polypeptides with a molecular receptors (IL-1RI and IL-1RII ), exert a wide range of weight ranging from 10 to 25 kDa that, produced by immune and inflammatory effects, whilst IL-1RA blocks IL-1 activity in vitro and in vivo by occupying is a polypeptide that is produced by macrophages and may induce fever. Moreover, it stimulates the proliferation and differentiation of B cells, the release of acutephase proteins from hepatocytes, and the proliferation of mesenchymal cells [8, 9] . IL-8 is a member of a large family of chemotactic peptides synthesized by macrophages, endothelial cells and fibroblasts known as chemokines. It is a potent chemotactic and activating factor for neutrophils [10] . Regarding TNF-a, two different isoforms are known: a and b. TNF-a is a pleiotrophic cytokine with biological properties similar to IL-1. When injected in animals and humans, it may cause hypotension, fever, leukopenia, as well as several metabolic dysfunctions that may evolve in a shocklike syndrome [11] . It has been demonstrated that the effect of TNF-a can be blocked by naturally occuring to the p55 and p75 cell surface TNF-a receptors [7] . IL-1 and TNF-a effects are mainly due to their ability to induce cyclo-oxygenase and phospholipase A 2 gene expression and, consequently, production of prostaglandins and platelet activating factor [12] . Finally, MCP-1, a chemokine produced by several cells includBetz et al. have demonstrated that cuprophan meming monocytes, is a potent and specific chemotactic branes stimulate IL-1 expression in monocytes in the and activating factor for monocytes. It has been shown absence of complement [14] . On the other hand, that both TNF-a and IL-1 together with LPS are the cellulosic membranes are known to activate the commost powerful inducers of this chemotactic peptide in plement cascade and it has been shown that complea variety of cells [13] .
The specific action of any of these monocyte-derived ment fractions generated during haemodialysis, such cytokines may be relevant in the pathogenesis of bioin-as C3a and C5a, stimulate IL-1 gene expression by compatibility clinical phenomena. This observation led monocytes [15] . The third possible pathogenetic factor several investigators to study the plasmatic levels of to consider in the increased cytokine production during these pro-inflammatory cytokines. As expected, most haemodialysis is the LPS fragments contaminating the of the studies showed a striking increase in IL-1, IL-6, dialysate and able to cross the membrane. Recently, it IL-8, TNF-a, and MCP-1 plasma levels [7, 8, 10, 13] . has been demonstrated that the basal release of TNFHowever, some studies reported also a clear increase a and IL-6 during haemodialysis is considerably influin the various cytokine-binding proteins, suggesting enced by the endotoxin content in dialysate, besides some, although incomplete, preservation of autoregula-the type of dialysis membrane used [16 ] . Indeed, it has tory mechanism [7] .
been shown that monocytes, isolated from uraemic patients treated with non-sterile bicarbonate tanks, spontaneously released a significantly greater amount
Mechanisms leading to cytokine induction during
of TNF-a and IL-6 compared to healthy controls and haemodialysis non-dialysed uraemic patients. This higher production was significantly reduced by the use of sterile- Figure 1 
depicts three of the most important mechan-bicarbonate tanks [14]. isms that have been shown to induce both in vitro as
The contact with the dialysis membrane as well as well as in vivo cytokine transcription and/or production the interactions with complement fractions, although during haemodialysis:
can induce a selective cytokine gene transcription in 1. Direct contact of peripheral blood mononuclear monocytes, do not always stimulate automatically the cells (PBMC ) with dialysis membrane. translation of the specific proteins. Indeed, we have 2. Complement fractions generated during haemo-previously shown that IL-6 gene expression is strikingly dialysis. increased during haemodialysis with cuprophan mem-3. LPS contaminated dialysate.
brane, but its protein secretion is clearly downregulated [17] . Interestingly, Schindler et al. have demonstrated The intrinsic nature of the dialysis material seems that recombinant C5a in vitro stimulates transcription to play an important role in cytokine induction during rather than translation of IL-1 and that LPS or IL-1 haemodialysis both directly and indirectly, through itself is required as a translational signal [15] . In complement activation. It is well known that, in the support of this hypothesis, we and others have demonabsence of any other stimulus, adherence to dialysis strated that patients treated with cuprophan have membrane induces selective mRNA expression of monocyte mediators and proto-oncogenes. Indeed, higher mRNA levels for different cytokines, but in order to obtain a higher translation, a second stimulus, refractory to further stimulation and are unable to mount a cytokine response to antigenic challenge. By such as LPS, is required [15, 16 ] .
contrast, the use of biocompatible membranes normalizes the ability of mononuclear cells to synthesize
Clinical relevance of cytokine production in
cytokines [24] . Malnutrition is a common feature in haemodialysed haemodialysis: acute and chronic effects patients and several reports have documented the adverse effect of malnutrition on morbidity and mortalThe production of cytokines during haemodialysis ity of these patients [25] . Patients on haemodialysis procedures, particularly when using bioincompatible show evidence of an accelerated catabolism, which is membranes, seems to be responsible for acute comparticularly evident on haemodialysis days. The altered plications such as fever, headache and hypotension, as protein metabolism may be referred to the loss of well as for long-term consequences such as dialysisamino acids induced by the dialytic procedure. related amyloidosis, increased susceptibility to infecHowever, several studies have underlined the possible tions, and increased muscle protein catabolism [18, 19] role of unsubstituted cellulosic membranes in enhan- ( Table 1) .
cing protein catabolism [26 ] . Moreover, experimental The incidence of amyloid bone disease is much evidence [27] supports the hypothesis that the enhanced greater in patients who have been dialysed with unsubproteolysis induced by cellulosic membranes is medistituted cellulosic membranes than with a biocompatated by monocyte activation and the subsequent release ible membrane [20] . m into amyloid fibrils [22] and et al. [30] who found that an imbalance between favour its intra-articular deposition. Because of these cytokines and their specific inhibitors may have delefactors, patients treated with low-flux cellulosic memterious effects on uraemic bone. Particularly, high branes are chronically exposed to a higher concentraplasma IL-1RA concentrations makes the skeleton tion of b 2 m. relatively insensitive to the stimulatory effect of IL-1 There is increasing evidence that bioincompatible on osteoblast; on the other hand, high soluble IL-6 membranes play an important role in enhancing susreceptor concentrations may balance the stimulatory ceptibility to infections in uraemic patients. The use of effect of IL-6 on osteoclast activity. These results cellulosic membranes is associated with dysfunction of strongly support the hypothesis that cytokines may phagocytic cells, natural killer cells, and other immunohave a pathogenetic role in the development of renal logical alterations, including altered cytokine producosteodystrophy. tion and complement system activation [23] . Growing Finally, the biocompatibility of the dialysis meminterest has been recently focused on inflammatory branes may play an important role in the resolution cytokine production during haemodialysis. Contact of of acute renal failure [31] and may, at least partially, mononuclear cells with a complement activating memaccount for the different morbidity and mortality rate brane results in accumulation of some cytokine between patients dialysed with cellulosic membranes mRNAs, such as IL-1, TNF-a, and IL-6 without a and those dialysed with synthetic membranes [32] . correspondent increased translation into protein [15, 17] . Monocytes are in a state of chronic activation when patients are on maintenance haemodialysis with Role of molecular biology techniques in the cellulosic membranes. As a result, monocyte became understanding of cytokine induction during haemodialysis Table 1 . Clinical consequences of cytokine production in haemodia-Several studies, performed both in vitro as well as in lysed patients vivo, have investigated the production of cytokines by PBMC from dialysis patients compared to normals Acute Chronic and uraemic patients not yet haemodialysed [4, 7, 9, 10] . Collectively, these studies can easily confuse the reader. Renal osteodystrophy
Moreover, in the last few years the discovery of cyto- [7] . The quality of the antibodies, the expressing MCP-1 mRNA in cuprophan-treated patients ( Figure 2) [35]. ELISA or RIA kits used were not always highly reliable. Studies using bioassays (considered useful in Although molecular biology techniques cannot demonstrate the clinical impact of an increased cytokine the past), in the lights of the discovery of cytokinespecific inhibitors, are now questionable.
mRNA concentration, at least they can help to identify the mechanisms leading to cytokine transcription The sum of these different pitfalls (interactions of cytokines with specific inhibitors, reliability of the during haemodialysis. Overall, the application of these techniques may shed light on the study of bioincompatantibodies and techniques used) make the study of cytokine production difficult to evaluate. Recently, the ibility of different dialysers and dialysis procedures. Of course, prospective controlled clinical studies are now introduction of molecular biological techniques to the study of 'cytokines and bioincompatibility' has over-warranted to determine the effective clinical consequences of cytokine transcription. come some of these difficulties [2] . Unlike bioassays, these techniques are highly specific and are not influenced by cytokine binding proteins and inhibitors.
Perspective
Indeed, using appropriate probes, these techniques allow the researcher to detect specific cytokine mRNAs and their cellular source. Recently, for example, apply-In summary, biocompatibility of membranes is an important concern in haemodialysis treatment. ing a RT-PCR technique, an increased expression of MCP-1 and C3 mRNA between normal and haemodia-Bioincompatible treatment may induce an inappropriate monocyte activation and cytokine production lysed patients has been demonstrated [35, 36 ] . Since the introduction of human recombinant erythro-study also included patients in the over 110 g/l range, poietin ( Epo) into clinical practice, numerous studies which includes Medicare patients receiving Epo and have evaluated the relationship between correction of requiring medical justification for haemoglobin levels the anaemia of chronic renal failure and the associated over 120 g/l. This latter factor places high risk patients changes in physiological and functional parameters in the over 110 g/l group along with the lower risk [1] . Early work showed marked increased exercise patients (haemoglobin levels ranging from 110 g/l to tolerance and improved oxygen consumption [2] [3] [4] [5] . 120 g/l ), requiring no justification for Epo and possibly Similarly, enhancement of brain function, as measured biasing the results in the higher haemoglobin group by visual evoked response time and cognitive function, with the sicker patients. Lastly, there were no evaluwere noted [6, 7] . A number of investigators have ations of comorbidity and disease severity in the shown improved cardiac function when haemato-National Medical Care data set. Given the strengths crit levels were increased from 25-30% [8] [9] [10] [11] [12] [13] [14] . and weaknesses, the study clearly showed the consistent Normalization of haematocrit levels has been studied association of haemoglobins less than 100 g/l with in only a small number of patients, but improved significantly higher mortality. Unfortunately, no exercise tolerance and reduced hospitalization rates definite conclusion can be made about the group were demonstrated [15, 16 ] . Although many studies with haemoglobins over 110 g/l, secondary to the have shown evidence of functional improvement, no comorbidity and insufficient power. studies have had adequate power to determine whether
We have recently reported, in preliminary form, the there are beneficial or adverse effects of higher relationship between haematocrit levels and associated haematocrit concentrations on patient survival or mortality and hospitalization in a large cohort of hospitalization.
Medicare patients [18] [19] [20] [21] . These studies evaluated Haematocrit/haemoglobin levels (haemoglobin con-prevalent patients at later periods of time than in centrations) have only recently been evaluated as a Madore's report, with six-and twelve-month intervals risk factor for mortality in ESRD patients in a mortal-of haematocrit determinations and with a longer ity model. Madore et al. recently published data on follow-up of one year. In our cohort, increased hospit-18 000 National Medical Care patients with haemo-alization rates and higher mortality rates were seen in globin levels determined over the last three months of patients with haematocrits below 30%, results which 1992, with follow-up into 1993 [17] . This study showed are similar to those reported by Madore et al. Fewer increased mortality associated with haemoglobins less hospitalizations and lower mortality were noted in than 100 g/l, compared to 100 to 110 g/l. Risk factors patients with haematocrits between 33 and 36%. included in the analysis were age, gender, race, renal Patients achieving these haematocrit levels had a diagnosis (as diabetic or non-diabetic), case mix adjust-7-15% lower risk (P value: 0.001), compared to ments by biochemical data and serum albumin, and patients with levels of 30-33%. Our studies were dialysis therapy by urea reduction ratio.
adjusted for comorbidity and disease severity but did The strength of the study included a large sample not account for dialysis therapy or nutritional status, size with adjustments for patient, clinical, and biochem-which were not reported in the Medicare claim data. ical factors, nutritional status, and dialysis therapy.
The issue that is still not clearly defined is that of The weaknesses in the study included a short period which haematocrit level is best for patient survival and of haemoglobin assessment, an ill-defined follow-up reduced morbidity. More recent studies of large patient period in 1993, a study period that included a time cohorts indicate that higher haematocrits in the range during which i.v. iron was not available in the United of 33-36%, or haemoglobins of 110-120 g/l, may be States, and a low number of patients in the higher associated with improved outcomes. These more recent haemoglobin group (>110 g/l; 2000 patients). The studies assessed medical interventions on a national basis and may give insight into large population health also resemble those of CsA. Like the latter drug, nisone, renal function and histology, as evaluated by repeated biopsies, improved dramatically [22] . tacrolimus is considered to be vasoconstrictive. A more renal but less systemic vasoconstriction than under CsA treatment has been reported [13] . Tacrolimus, in contrast to CsA, does not lower prostacyclin levels at Practical considerations comparable immunosuppressive doses, at least in vitro [14] . However, like CsA, tacrolimus increases the On the basis of our own experience and a review of production of the vasoconstrictors thromboxane A 2 the available data in the literature, we suggest that in and endothelin [15] and inhibits nitric oxide synthase patients suspected of CsA-or tacrolimus-induced HUS activation [16 ] .
both of these substances be omitted. In such cases immunosuppressive therapy with mycophenolate mofetil and steroids had been proposed [23] . It is
